Artificial intelligence offers transformative potential to improve diagnostic accuracy and risk stratification for inherited cardiomyopathies, particularly in under-resourced settings.
Does artificial intelligence improve risk stratification and diagnostic accuracy for inherited cardiomyopathies in under-resourced settings?
Artificial intelligence has the potential to improve diagnostic accuracy and risk stratification for inherited cardiomyopathies, particularly in under-resourced settings.
Inherited cardiomyopathies are a significant global cause of sudden cardiac death, particularly among younger individuals and those in under-resourced regions. Despite progress in diagnostics and therapeutics, screening and risk stratification remain challenging due to genetic complexity, variable clinical presentation, and the interpretive limitations of current electrophysiological and imaging tools. Artificial intelligence (AI)-particularly machine learning, deep learning, and natural language processing offers transformative potential by enabling large-scale analysis of complex data and detecting subtle disease patterns which could potentially improve diagnostic accuracy and cost-effectiveness, particularly in low-resource environments. This review evaluates the limitations of existing risk models, synthesizes disease-specific AI applications within a unified framework, and explores the role of AI in advancing personalized care and risk prediction in underserved populations.
Alahwany et al. (Tue,) conducted a review in Inherited cardiomyopathies. Artificial intelligence was evaluated. Artificial intelligence offers transformative potential to improve diagnostic accuracy and risk stratification for inherited cardiomyopathies, particularly in under-resourced settings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: